Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation Efforts Offer A Way To Change FDA's Views On Risk, Industry Says

This article was originally published in The Gray Sheet

Executive Summary

FDA should put more emphasis on product benefits and patients' willingness to take on risk in pre-market reviews of particularly innovative devices, industry participants argued during an agency workshop last week.

You may also be interested in...



Risk-Benefit Guidance Aims To Improve Pre-Market Review Predictability

It takes more than safety and effectiveness data alone for FDA device reviewers to determine how benefits stack up against risks in a pre-market submission, the agency accentuates in new draft guidance.

Risk-Benefit Guidance Aims To Improve Pre-Market Review Predictability

It takes more than safety and effectiveness data alone for FDA device reviewers to determine how benefits stack up against risks in a pre-market submission, the agency accentuates in new draft guidance.

Shuren: New Clinical Trial Guidelines In The Works

FDA device center director Jeffrey Shuren says new guidance documents coming down the pike will clarify issues related to clinical trial design and approval.

Related Content

Topics

UsernamePublicRestriction

Register

PS100968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel